PTPN3 and neoplasm: This study provided evidence for the prognostic value of PTPN3 in pan-cancer, and its critical roles in mediating cancer drug sensitivity, tumor immune microenvironment, and immunotherapy efficacy, providing a novel biomarker and immunotherapeutic target for cancer treatment and facilitating the development of more precise and personalized immunotherapy strategies.